Thrombosis & Thromboembolism 2022 (CME VIDEOS)

Overview

Thrombosis & Thromboembolism 2022 (CME VIDEOS) is an on-demand CME course from the North American Thrombosis Forum that provides a comprehensive review of significant advances and changes in the care of patients with or at risk for thrombotic disorders. This course features world-renowned experts presenting updates on the prevention, diagnosis, and treatment of thrombosis and related conditions.

On-demand cardiology education — accessible anytime, anywhere.

Agenda

The curriculum covers diverse topics relevant to thrombotic diseases, presented by leading clinical faculty.

• Novel Targets For Atherosclerosis Prevention — Aruna D. Pradhan, MD, MPH, MSc
• What’s New with Lp(a) — Samia Mora, MD
• What’s New with LDL and ApoB — Jorge Plutzky, MD
• What’s New with Inflammatory Targets — Paul M. Ridker, MD, MPH
• Peripheral Arterial Disease: Pathways for Optimizing Cardiovascular and Limb Outcomes — Marc P. Bonaca, MD, MPH
• Heart Failure and Venous Thromboembolism — Samuel Z. Goldhaber, MD
• More Than Just Diabetes and Heart Failure – SGLT2 — Deepak L. Bhatt, MD, MPH
• More Than Just Diabetes and Heart Failure – GLP1 — Brendan M. Everett, MD, MPH
• Heart Failure – Reduced Ejection Fraction — Marc A. Pfeffer, MD, PhD
• Heart Failure – Preserved Ejection Fraction — Scott D. Solomon, PhD
• Heart Failure – Middle-of-the-Road Ejection Fraction – Navigating the Alphabet Soup — Michele A. Hamilton, MD
• CMR Imaging of Heart Failure — Raymond Y. Kwong, MD, MPH
• Dual Antiplatelet Therapy and Anticoagulation — Michelle L. O’Donoghue, MD, MPH
• Management of Anticoagulation Around Ablation, Cardioversions, and Watchmans for Atrial Fibrillation — Bruce A. Koplan, MD
• Dose-Reduced Direct Oral Anticoagulants: Efficacy and Safety — Behnood Bikdeli, MD, MS
• Duration of Anticoagulation for Arterial Thrombosis — Teresa Carman, MD, RPVI, MSVM
• Duration of Anticoagulation for Venous Thrombosis — Gregory Piazza, MD, MS
• Novel Anticoagulation Targets: Factor XI and XII Inhibitors — Jeffrey I. Weitz, MD
• Racial Disparities in Healthcare — Cassandra M. Pierre, MD, MSc
• Racial Disparities in Arterial and Venous Thrombosis — Karlyn A. Martin, MD
• VTE Prediction Using Genetics — Nicholas A. Marston, MD, MPH
• Clonal Hematopoiesis of Indeterminate Potential (CHIP) and Associations with VTE & PAD — Peter Libby, MD
• COVID and Thrombosis: Mechanisms and Epidemiology — Gregory Piazza, MD, MS
• Prevention of VTE in COVID-19 Patients — Behnood Bikdeli, MD, MS
• VTE Prophylaxis for Orthopedic Surgery — Samuel Z. Goldhaber, MD
• Device Therapy for PE Reperfusion — Gregory Piazza, MD, MS
• Systemic Fibrinolysis (PEITHO-3) — Samuel Z. Goldhaber, MD
• Adventures with Hypertrophic Cardiomyopathy – 1958-2022 — Eugene Braunwald, MD
• Chronic Thromboembolic Pulmonary Hypertension — Bradley A. Maron, MD
• Pulmonary Hypertension After PE That Is Not Chronic Thromboembolic Pulmonary Hypertension — Jane A. Leopold, MD, FACC, FAHA, FSCAIc
• Post-thrombotic Syndrome: Epidemiology and Medical Therapy — Susan R. Kahn, MD, MSc, FRCPC, ABIM
• Intervention and Chronic Venous Obstructive Disease — Suresh Vedantham, MD
• Vascular Cardio-Oncology — Javid Moslehi, MD
• Prevention of Thrombotic Complications of Cancer and Cancer Therapy — Simon Mantha, MD, MPH
• Treatment of Cancer-Associated Thrombosis — Michael B. Streiff, MD

Learning Objectives

At the conclusion of this activity, participants will be able to:

• Identify the etiology and pathophysiology of atherothrombosis
• Recognize the link between inflammation and thrombotic illnesses
• Explain new tools for stroke prevention and prediction in atrial fibrillation
• Identify optimal anticoagulation duration for pulmonary embolism (PE) and deep vein thrombosis (DVT)
• Provide advanced therapies such as thrombolysis, catheter-directed therapy, and surgical embolectomy
• Explain the connection between diabetes, metabolic syndrome, and major adverse cardiac events
• Advise patients on heart-healthy diets to help prevent thrombosis
• Manage care for high-risk pregnancies involving thrombosis risk

Speakers

• Aruna D. Pradhan, MD, MPH, MSc
• Samia Mora, MD
• Jorge Plutzky, MD
• Paul M. Ridker, MD, MPH
• John F. Keaney, Jr., MD
• Marc P. Bonaca, MD, MPH
• Marie D. Gerhard-Herman, MD
• Samuel Z. Goldhaber, MD
• Deepak L. Bhatt, MD, MPH
• Brendan M. Everett, MD, MPH
• Marc A. Pfeffer, MD, PhD
• Akshay Suvas Desai, MD, MPH
• Scott D. Solomon, PhD
• Michele A. Hamilton, MD
• Raymond Y. Kwong, MD, MPH
• Michelle L. O’Donoghue, MD, MPH
• Bruce A. Koplan, MD
• Behnood Bikdeli, MD, MS
• Teresa Carman, MD, RPVI, MSVM
• Gregory Piazza, MD, MS
• Jeffrey I. Weitz, MD
• Cassandra M. Pierre, MD, MSc
• Karlyn A. Martin, MD
• Nicholas A. Marston, MD, MPH
• Peter Libby, MD
• Samuel Z. Goldhaber, MD
• Ebrahim Barkoudah, MD, MPH
• Eugene Braunwald, MD
• Bradley A. Maron, MD
• Jane A. Leopold, MD, FACC, FAHA, FSCAIc
• Susan R. Kahn, MD, MSc, FRCPC, ABIM
• Suresh Vedantham, MD
• Javid Moslehi, MD
• Simon Mantha, MD, MPH
• Michael B. Streiff, MD
• Jean Connors, MD

This educational activity was developed by the North American Thrombosis Forum. The course was released on December 31, 2022, with CME credits available until December 31, 2025.

Target Audience

This course is intended for physicians, nurse practitioners, and physician assistants seeking current information on the management of patients with or at risk for thrombotic disorders.

Why This Topic Matters

Thrombosis & Thromboembolism 2022 (CME VIDEOS) addresses critical updates in the understanding and management of thrombotic conditions relevant to cardiology, hematology, and vascular medicine. The course presents evidence-based insights to strengthen clinical expertise in areas such as anticoagulation strategies, advanced therapies, and disease prevention.

Incorporating this knowledge through MedHub Central supports practitioners in confidently navigating complex thrombotic cases and improving patient care with current scientific advances.